128 related articles for article (PubMed ID: 12881194)
1. PEG-PE/phosphatidylcholine mixed immunomicelles specifically deliver encapsulated taxol to tumor cells of different origin and promote their efficient killing.
Gao Z; Lukyanov AN; Chakilam AR; Torchilin VP
J Drug Target; 2003 Feb; 11(2):87-92. PubMed ID: 12881194
[TBL] [Abstract][Full Text] [Related]
2. Mixed PEG-PE/vitamin E tumor-targeted immunomicelles as carriers for poorly soluble anti-cancer drugs: improved drug solubilization and enhanced in vitro cytotoxicity.
Sawant RR; Sawant RM; Torchilin VP
Eur J Pharm Biopharm; 2008 Sep; 70(1):51-7. PubMed ID: 18583114
[TBL] [Abstract][Full Text] [Related]
3. pH-sensitive poly(histidine)-PEG/DSPE-PEG co-polymer micelles for cytosolic drug delivery.
Wu H; Zhu L; Torchilin VP
Biomaterials; 2013 Jan; 34(4):1213-22. PubMed ID: 23102622
[TBL] [Abstract][Full Text] [Related]
4. Photodynamic therapy of experimental B-16 melanoma in mice with tumor-targeted 5,10,15,20-tetraphenylporphin-loaded PEG-PE micelles.
Skidan I; Dholakia P; Torchilin V
J Drug Target; 2008 Jul; 16(6):486-93. PubMed ID: 18604661
[TBL] [Abstract][Full Text] [Related]
5. Accumulation and toxicity of antibody-targeted doxorubicin-loaded PEG-PE micelles in ovarian cancer cell spheroid model.
Perche F; Patel NR; Torchilin VP
J Control Release; 2012 Nov; 164(1):95-102. PubMed ID: 22974689
[TBL] [Abstract][Full Text] [Related]
6. Tumor-targeted liposomes: doxorubicin-loaded long-circulating liposomes modified with anti-cancer antibody.
Lukyanov AN; Elbayoumi TA; Chakilam AR; Torchilin VP
J Control Release; 2004 Nov; 100(1):135-44. PubMed ID: 15491817
[TBL] [Abstract][Full Text] [Related]
7. Immunomicelles: targeted pharmaceutical carriers for poorly soluble drugs.
Torchilin VP; Lukyanov AN; Gao Z; Papahadjopoulos-Sternberg B
Proc Natl Acad Sci U S A; 2003 May; 100(10):6039-44. PubMed ID: 12716967
[TBL] [Abstract][Full Text] [Related]
8. Cyclic RGD conjugated poly(ethylene glycol)-co-poly(lactic acid) micelle enhances paclitaxel anti-glioblastoma effect.
Zhan C; Gu B; Xie C; Li J; Liu Y; Lu W
J Control Release; 2010 Apr; 143(1):136-42. PubMed ID: 20056123
[TBL] [Abstract][Full Text] [Related]
9. PEG-PE-based micelles co-loaded with paclitaxel and cyclosporine A or loaded with paclitaxel and targeted by anticancer antibody overcome drug resistance in cancer cells.
Sarisozen C; Vural I; Levchenko T; Hincal AA; Torchilin VP
Drug Deliv; 2012 May; 19(4):169-76. PubMed ID: 22506922
[TBL] [Abstract][Full Text] [Related]
10. Solubilization of poorly soluble PDT agent, meso-tetraphenylporphin, in plain or immunotargeted PEG-PE micelles results in dramatically improved cancer cell killing in vitro.
Roby A; Erdogan S; Torchilin VP
Eur J Pharm Biopharm; 2006 Apr; 62(3):235-40. PubMed ID: 16326084
[TBL] [Abstract][Full Text] [Related]
11. Mixed micelles of PEG(2000)-DSPE and vitamin-E TPGS for concurrent delivery of paclitaxel and parthenolide: enhanced chemosenstization and antitumor efficacy against non-small cell lung cancer (NSCLC) cell lines.
Gill KK; Kaddoumi A; Nazzal S
Eur J Pharm Sci; 2012 May; 46(1-2):64-71. PubMed ID: 22369858
[TBL] [Abstract][Full Text] [Related]
12. p-Nitrophenylcarbonyl-PEG-PE-liposomes: fast and simple attachment of specific ligands, including monoclonal antibodies, to distal ends of PEG chains via p-nitrophenylcarbonyl groups.
Torchilin VP; Levchenko TS; Lukyanov AN; Khaw BA; Klibanov AL; Rammohan R; Samokhin GP; Whiteman KR
Biochim Biophys Acta; 2001 Apr; 1511(2):397-411. PubMed ID: 11286983
[TBL] [Abstract][Full Text] [Related]
13. EGFR-targeted poly(ethylene glycol)-distearoylphosphatidylethanolamine micelle loaded with paclitaxel for laryngeal cancer: preparation, characterization and in vitro evaluation.
Ren H; Gao C; Zhou L; Liu M; Xie C; Lu W
Drug Deliv; 2015; 22(6):785-94. PubMed ID: 24670093
[TBL] [Abstract][Full Text] [Related]
14. Enhanced in vivo antitumor efficacy of poorly soluble PDT agent, meso-tetraphenylporphine, in PEG-PE-based tumor-targeted immunomicelles.
Roby A; Erdogan S; Torchilin VP
Cancer Biol Ther; 2007 Jul; 6(7):1136-42. PubMed ID: 17611407
[TBL] [Abstract][Full Text] [Related]
15. Antinucleosome antibody-modified liposomes and lipid-core micelles for tumor-targeted delivery of therapeutic and diagnostic agents.
Elbayoumi TA; Pabba S; Roby A; Torchilin VP
J Liposome Res; 2007; 17(1):1-14. PubMed ID: 17454399
[TBL] [Abstract][Full Text] [Related]
16. Free paclitaxel loaded PEGylated-paclitaxel nanoparticles: preparation and comparison with other paclitaxel systems in vitro and in vivo.
Lu J; Chuan X; Zhang H; Dai W; Wang X; Wang X; Zhang Q
Int J Pharm; 2014 Aug; 471(1-2):525-35. PubMed ID: 24858391
[TBL] [Abstract][Full Text] [Related]
17. Long-circulating PEG-PE micelles co-loaded with paclitaxel and elacridar (GG918) overcome multidrug resistance.
Sarisozen C; Vural I; Levchenko T; Hincal AA; Torchilin VP
Drug Deliv; 2012 Nov; 19(8):363-70. PubMed ID: 23030458
[TBL] [Abstract][Full Text] [Related]
18. Monoclonal Antibody 2C5-Modified Mixed Dendrimer Micelles for Tumor-Targeted Codelivery of Chemotherapeutics and siRNA.
Pan J; Attia SA; Subhan MA; Filipczak N; Mendes LP; Li X; Kishan Yalamarty SS; Torchilin VP
Mol Pharm; 2020 May; 17(5):1638-1647. PubMed ID: 32233497
[TBL] [Abstract][Full Text] [Related]
19. Novel self-assembling PEG-p-(CL-co-TMC) polymeric micelles as safe and effective delivery system for paclitaxel.
Danhier F; Magotteaux N; Ucakar B; Lecouturier N; Brewster M; Préat V
Eur J Pharm Biopharm; 2009 Oct; 73(2):230-8. PubMed ID: 19577643
[TBL] [Abstract][Full Text] [Related]
20. Multifunctional PEGylated 2C5-immunoliposomes containing pH-sensitive bonds and TAT peptide for enhanced tumor cell internalization and cytotoxicity.
Koren E; Apte A; Jani A; Torchilin VP
J Control Release; 2012 Jun; 160(2):264-73. PubMed ID: 22182771
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
